Structure

Physi-Chem Properties

Molecular Weight:  145.07
Volume:  138.507
LogP:  -2.718
LogD:  -1.04
LogS:  -0.195
# Rotatable Bonds:  1
TPSA:  69.56
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  1
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.451
Synthetic Accessibility Score:  3.269
Fsp3:  0.833
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.9
MDCK Permeability:  0.0006799382390454412
Pgp-inhibitor:  0.001
Pgp-substrate:  0.024
Human Intestinal Absorption (HIA):  0.148
20% Bioavailability (F20%):  0.152
30% Bioavailability (F30%):  0.976

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.381
Plasma Protein Binding (PPB):  11.344656944274902%
Volume Distribution (VD):  0.536
Pgp-substrate:  93.25519561767578%

ADMET: Metabolism

CYP1A2-inhibitor:  0.007
CYP1A2-substrate:  0.066
CYP2C19-inhibitor:  0.031
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.324
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.174
CYP3A4-inhibitor:  0.003
CYP3A4-substrate:  0.018

ADMET: Excretion

Clearance (CL):  5.55
Half-life (T1/2):  0.662

ADMET: Toxicity

hERG Blockers:  0.018
Human Hepatotoxicity (H-HT):  0.076
Drug-inuced Liver Injury (DILI):  0.018
AMES Toxicity:  0.016
Rat Oral Acute Toxicity:  0.02
Maximum Recommended Daily Dose:  0.58
Skin Sensitization:  0.426
Carcinogencity:  0.154
Eye Corrosion:  0.308
Eye Irritation:  0.789
Respiratory Toxicity:  0.517

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC10721

Natural Product ID:  NPC10721
Common Name*:   NFCYJOSYKJZRIJ-UHNTWSMTSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  NFCYJOSYKJZRIJ-UHNTWSMTSA-N
Standard InCHI:  InChI=1S/C35H52O7/c1-8-10-11-12-13-14-15-16-28(37)42-35-30(33(35,6)7)27-19-24(20-36)18-25-26(17-22(4)29(25)38)34(27,40)23(5)31(35)41-32(39)21(3)9-2/h9,17,19,23,25-27,30-31,36,40H,8,10-16,18,20H2,1-7H3/b21-9+/t23-,25-,26-,27+,30-,31-,34+,35-/m1/s1
SMILES:  CCCCCCCCCC(=O)O[C@]12[C@H]([C@@H]3C=C(C[C@@H]4[C@@H](C=C(C)C4=O)[C@]3([C@H](C)[C@H]1OC(=O)/C(=C/C)/C)O)CO)C2(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2375790
PubChem CID:   73351893
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0002875] Tigliane and ingenane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. seed n.a. PMID[21049973]
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[23701597]
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[25819096]
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO2978 Croton tiglium Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT890 Cell Line SNU-387 Homo sapiens IC50 > 10000.0 nM PMID[494167]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC10721 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9907 High Similarity NPC154363
0.9907 High Similarity NPC234858
0.9907 High Similarity NPC471127
0.9727 High Similarity NPC329080
0.9727 High Similarity NPC472759
0.9725 High Similarity NPC146280
0.9725 High Similarity NPC124676
0.972 High Similarity NPC472757
0.964 High Similarity NPC52839
0.9636 High Similarity NPC156745
0.9636 High Similarity NPC236918
0.963 High Similarity NPC472400
0.955 High Similarity NPC471128
0.955 High Similarity NPC145182
0.955 High Similarity NPC157252
0.955 High Similarity NPC475885
0.955 High Similarity NPC471126
0.9459 High Similarity NPC22628
0.9459 High Similarity NPC5991
0.9459 High Similarity NPC275696
0.9459 High Similarity NPC471108
0.9459 High Similarity NPC255081
0.9459 High Similarity NPC5989
0.9386 High Similarity NPC145238
0.9381 High Similarity NPC162009
0.9381 High Similarity NPC257017
0.9369 High Similarity NPC471125
0.9369 High Similarity NPC171905
0.9369 High Similarity NPC472758
0.9369 High Similarity NPC472397
0.9298 High Similarity NPC472399
0.9279 High Similarity NPC156252
0.9211 High Similarity NPC19464
0.9182 High Similarity NPC71889
0.9123 High Similarity NPC472401
0.9099 High Similarity NPC474872
0.9091 High Similarity NPC215643
0.9091 High Similarity NPC89227
0.9091 High Similarity NPC101825
0.9091 High Similarity NPC170212
0.9091 High Similarity NPC151216
0.9091 High Similarity NPC265499
0.9091 High Similarity NPC221511
0.9091 High Similarity NPC17138
0.9035 High Similarity NPC185876
0.9035 High Similarity NPC19336
0.9027 High Similarity NPC472760
0.9009 High Similarity NPC474937
0.9 High Similarity NPC174471
0.9 High Similarity NPC474871
0.9 High Similarity NPC96739
0.9 High Similarity NPC260786
0.9 High Similarity NPC475937
0.9 High Similarity NPC158523
0.8947 High Similarity NPC180640
0.8919 High Similarity NPC475391
0.8909 High Similarity NPC153036
0.8824 High Similarity NPC270109
0.8772 High Similarity NPC153651
0.8729 High Similarity NPC473919
0.8729 High Similarity NPC473709
0.8689 High Similarity NPC476111
0.8673 High Similarity NPC477091
0.8655 High Similarity NPC222307
0.8649 High Similarity NPC163004
0.8649 High Similarity NPC273433
0.8644 High Similarity NPC473802
0.8621 High Similarity NPC472667
0.8583 High Similarity NPC471940
0.8512 High Similarity NPC236999
0.85 High Similarity NPC471939
0.8468 Intermediate Similarity NPC187435
0.8468 Intermediate Similarity NPC67321
0.8455 Intermediate Similarity NPC189393
0.8455 Intermediate Similarity NPC90814
0.839 Intermediate Similarity NPC143755
0.8347 Intermediate Similarity NPC293112
0.8333 Intermediate Similarity NPC469656
0.8333 Intermediate Similarity NPC469655
0.8333 Intermediate Similarity NPC474846
0.8319 Intermediate Similarity NPC310511
0.8305 Intermediate Similarity NPC469380
0.8304 Intermediate Similarity NPC143609
0.8291 Intermediate Similarity NPC469684
0.8273 Intermediate Similarity NPC476081
0.8261 Intermediate Similarity NPC472002
0.8261 Intermediate Similarity NPC470063
0.8246 Intermediate Similarity NPC253906
0.8246 Intermediate Similarity NPC257240
0.823 Intermediate Similarity NPC306265
0.8214 Intermediate Similarity NPC111952
0.8211 Intermediate Similarity NPC470850
0.8205 Intermediate Similarity NPC179626
0.8205 Intermediate Similarity NPC471816
0.8205 Intermediate Similarity NPC470793
0.8197 Intermediate Similarity NPC473635
0.8189 Intermediate Similarity NPC243902
0.8182 Intermediate Similarity NPC11895
0.8182 Intermediate Similarity NPC469789
0.8167 Intermediate Similarity NPC67569
0.816 Intermediate Similarity NPC475139
0.816 Intermediate Similarity NPC180902
0.8158 Intermediate Similarity NPC475586
0.8151 Intermediate Similarity NPC470186
0.8151 Intermediate Similarity NPC475041
0.8145 Intermediate Similarity NPC104382
0.8145 Intermediate Similarity NPC470851
0.8136 Intermediate Similarity NPC475323
0.8136 Intermediate Similarity NPC473656
0.8125 Intermediate Similarity NPC118911
0.812 Intermediate Similarity NPC138303
0.812 Intermediate Similarity NPC133677
0.812 Intermediate Similarity NPC67290
0.8115 Intermediate Similarity NPC81736
0.8115 Intermediate Similarity NPC172154
0.8108 Intermediate Similarity NPC137430
0.8108 Intermediate Similarity NPC162973
0.8103 Intermediate Similarity NPC152117
0.8103 Intermediate Similarity NPC234042
0.8103 Intermediate Similarity NPC269530
0.8099 Intermediate Similarity NPC23786
0.8099 Intermediate Similarity NPC470265
0.8099 Intermediate Similarity NPC170538
0.8091 Intermediate Similarity NPC470074
0.8091 Intermediate Similarity NPC47024
0.8091 Intermediate Similarity NPC474718
0.8087 Intermediate Similarity NPC472214
0.8087 Intermediate Similarity NPC477103
0.8087 Intermediate Similarity NPC5103
0.8087 Intermediate Similarity NPC472215
0.8083 Intermediate Similarity NPC268530
0.8083 Intermediate Similarity NPC154491
0.8083 Intermediate Similarity NPC48692
0.8083 Intermediate Similarity NPC4548
0.808 Intermediate Similarity NPC471170
0.807 Intermediate Similarity NPC308191
0.807 Intermediate Similarity NPC469916
0.807 Intermediate Similarity NPC472439
0.8051 Intermediate Similarity NPC176840
0.8045 Intermediate Similarity NPC140021
0.8036 Intermediate Similarity NPC61442
0.8036 Intermediate Similarity NPC8196
0.8036 Intermediate Similarity NPC99266
0.8036 Intermediate Similarity NPC120321
0.8034 Intermediate Similarity NPC46269
0.8034 Intermediate Similarity NPC106395
0.8034 Intermediate Similarity NPC25909
0.8034 Intermediate Similarity NPC477126
0.8034 Intermediate Similarity NPC469454
0.8034 Intermediate Similarity NPC469463
0.8034 Intermediate Similarity NPC469496
0.8034 Intermediate Similarity NPC471204
0.8033 Intermediate Similarity NPC469352
0.8033 Intermediate Similarity NPC469382
0.8033 Intermediate Similarity NPC473979
0.8031 Intermediate Similarity NPC473548
0.8031 Intermediate Similarity NPC471136
0.8031 Intermediate Similarity NPC100017
0.8031 Intermediate Similarity NPC182266
0.8031 Intermediate Similarity NPC475154
0.8031 Intermediate Similarity NPC471137
0.8031 Intermediate Similarity NPC476823
0.8031 Intermediate Similarity NPC475500
0.8031 Intermediate Similarity NPC223356
0.8018 Intermediate Similarity NPC471412
0.8017 Intermediate Similarity NPC4021
0.8017 Intermediate Similarity NPC317107
0.8017 Intermediate Similarity NPC475668
0.8017 Intermediate Similarity NPC287311
0.8017 Intermediate Similarity NPC470076
0.8017 Intermediate Similarity NPC159456
0.8017 Intermediate Similarity NPC475480
0.8017 Intermediate Similarity NPC473921
0.8 Intermediate Similarity NPC473636
0.8 Intermediate Similarity NPC175186
0.8 Intermediate Similarity NPC216478
0.8 Intermediate Similarity NPC312536
0.8 Intermediate Similarity NPC77689
0.8 Intermediate Similarity NPC231529
0.8 Intermediate Similarity NPC473839
0.8 Intermediate Similarity NPC173905
0.8 Intermediate Similarity NPC477102
0.8 Intermediate Similarity NPC284828
0.8 Intermediate Similarity NPC469370
0.8 Intermediate Similarity NPC211093
0.8 Intermediate Similarity NPC162495
0.8 Intermediate Similarity NPC472216
0.8 Intermediate Similarity NPC5475
0.7984 Intermediate Similarity NPC475273
0.7984 Intermediate Similarity NPC168849
0.7984 Intermediate Similarity NPC298841
0.7983 Intermediate Similarity NPC312824
0.7983 Intermediate Similarity NPC473968
0.7983 Intermediate Similarity NPC98249
0.7983 Intermediate Similarity NPC284068
0.7983 Intermediate Similarity NPC470493
0.7983 Intermediate Similarity NPC13713
0.7983 Intermediate Similarity NPC183580
0.7983 Intermediate Similarity NPC58662
0.7983 Intermediate Similarity NPC53396

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC10721 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8246 Intermediate Similarity NPD6371 Approved
0.7857 Intermediate Similarity NPD5344 Discontinued
0.7845 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD7115 Discovery
0.7778 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7611 Intermediate Similarity NPD6648 Approved
0.7522 Intermediate Similarity NPD4225 Approved
0.7521 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD7639 Approved
0.7456 Intermediate Similarity NPD7640 Approved
0.7368 Intermediate Similarity NPD7638 Approved
0.7355 Intermediate Similarity NPD8297 Approved
0.7311 Intermediate Similarity NPD6686 Approved
0.7227 Intermediate Similarity NPD7899 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD7507 Approved
0.7207 Intermediate Similarity NPD6698 Approved
0.7207 Intermediate Similarity NPD46 Approved
0.7188 Intermediate Similarity NPD7604 Phase 2
0.7176 Intermediate Similarity NPD7319 Approved
0.7167 Intermediate Similarity NPD6899 Approved
0.7167 Intermediate Similarity NPD6881 Approved
0.7154 Intermediate Similarity NPD4632 Approved
0.7143 Intermediate Similarity NPD6402 Approved
0.7143 Intermediate Similarity NPD7128 Approved
0.7143 Intermediate Similarity NPD6008 Approved
0.7143 Intermediate Similarity NPD5739 Approved
0.7143 Intermediate Similarity NPD7516 Approved
0.7143 Intermediate Similarity NPD6675 Approved
0.7131 Intermediate Similarity NPD6649 Approved
0.7131 Intermediate Similarity NPD8130 Phase 1
0.7131 Intermediate Similarity NPD6650 Approved
0.7107 Intermediate Similarity NPD6372 Approved
0.7107 Intermediate Similarity NPD6373 Approved
0.7105 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD6319 Approved
0.7083 Intermediate Similarity NPD5697 Approved
0.7073 Intermediate Similarity NPD6053 Discontinued
0.7063 Intermediate Similarity NPD7328 Approved
0.7063 Intermediate Similarity NPD7327 Approved
0.7049 Intermediate Similarity NPD7290 Approved
0.7049 Intermediate Similarity NPD7102 Approved
0.7049 Intermediate Similarity NPD6883 Approved
0.7025 Intermediate Similarity NPD7320 Approved
0.7 Intermediate Similarity NPD7492 Approved
0.6992 Remote Similarity NPD6847 Approved
0.6992 Remote Similarity NPD6617 Approved
0.6992 Remote Similarity NPD6869 Approved
0.6984 Remote Similarity NPD6009 Approved
0.6983 Remote Similarity NPD7902 Approved
0.697 Remote Similarity NPD7736 Approved
0.6967 Remote Similarity NPD6014 Approved
0.6967 Remote Similarity NPD6012 Approved
0.6967 Remote Similarity NPD6013 Approved
0.6953 Remote Similarity NPD6054 Approved
0.6947 Remote Similarity NPD6616 Approved
0.6942 Remote Similarity NPD5701 Approved
0.6935 Remote Similarity NPD6882 Approved
0.693 Remote Similarity NPD6399 Phase 3
0.6903 Remote Similarity NPD7838 Discovery
0.6899 Remote Similarity NPD8379 Approved
0.6899 Remote Similarity NPD5983 Phase 2
0.6899 Remote Similarity NPD8033 Approved
0.6899 Remote Similarity NPD8335 Approved
0.6899 Remote Similarity NPD8296 Approved
0.6899 Remote Similarity NPD8380 Approved
0.6899 Remote Similarity NPD8378 Approved
0.6894 Remote Similarity NPD7078 Approved
0.6894 Remote Similarity NPD8293 Discontinued
0.6891 Remote Similarity NPD5211 Phase 2
0.6891 Remote Similarity NPD7632 Discontinued
0.6885 Remote Similarity NPD6011 Approved
0.687 Remote Similarity NPD7748 Approved
0.6846 Remote Similarity NPD6370 Approved
0.6829 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6822 Remote Similarity NPD8294 Approved
0.6822 Remote Similarity NPD6059 Approved
0.6822 Remote Similarity NPD8377 Approved
0.6818 Remote Similarity NPD6336 Discontinued
0.6814 Remote Similarity NPD1695 Approved
0.6794 Remote Similarity NPD8328 Phase 3
0.678 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6777 Remote Similarity NPD5141 Approved
0.6769 Remote Similarity NPD8517 Approved
0.6769 Remote Similarity NPD8515 Approved
0.6769 Remote Similarity NPD8516 Approved
0.6769 Remote Similarity NPD6015 Approved
0.6769 Remote Similarity NPD6921 Approved
0.6769 Remote Similarity NPD8513 Phase 3
0.6769 Remote Similarity NPD6016 Approved
0.6757 Remote Similarity NPD1694 Approved
0.6754 Remote Similarity NPD5785 Approved
0.6746 Remote Similarity NPD8133 Approved
0.6724 Remote Similarity NPD7900 Approved
0.6724 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6723 Remote Similarity NPD5286 Approved
0.6723 Remote Similarity NPD4696 Approved
0.6723 Remote Similarity NPD5285 Approved
0.672 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6718 Remote Similarity NPD5988 Approved
0.6696 Remote Similarity NPD7515 Phase 2
0.6696 Remote Similarity NPD7983 Approved
0.6696 Remote Similarity NPD6079 Approved
0.6695 Remote Similarity NPD6083 Phase 2
0.6695 Remote Similarity NPD6084 Phase 2
0.6695 Remote Similarity NPD4755 Approved
0.6667 Remote Similarity NPD5328 Approved
0.6667 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6412 Phase 2
0.6641 Remote Similarity NPD6274 Approved
0.6641 Remote Similarity NPD7503 Approved
0.664 Remote Similarity NPD4634 Approved
0.6638 Remote Similarity NPD5779 Approved
0.6638 Remote Similarity NPD5778 Approved
0.6636 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6615 Remote Similarity NPD7100 Approved
0.6615 Remote Similarity NPD7101 Approved
0.6612 Remote Similarity NPD5224 Approved
0.6612 Remote Similarity NPD5226 Approved
0.6612 Remote Similarity NPD5225 Approved
0.6612 Remote Similarity NPD4633 Approved
0.6607 Remote Similarity NPD1696 Phase 3
0.6607 Remote Similarity NPD1733 Clinical (unspecified phase)
0.6587 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6583 Remote Similarity NPD4700 Approved
0.6581 Remote Similarity NPD5282 Discontinued
0.6569 Remote Similarity NPD7260 Phase 2
0.6557 Remote Similarity NPD5174 Approved
0.6557 Remote Similarity NPD5175 Approved
0.6552 Remote Similarity NPD8035 Phase 2
0.6552 Remote Similarity NPD7637 Suspended
0.6552 Remote Similarity NPD8034 Phase 2
0.6549 Remote Similarity NPD3618 Phase 1
0.6538 Remote Similarity NPD6335 Approved
0.6529 Remote Similarity NPD5223 Approved
0.6525 Remote Similarity NPD5695 Phase 3
0.6519 Remote Similarity NPD8074 Phase 3
0.65 Remote Similarity NPD5696 Approved
0.6496 Remote Similarity NPD4202 Approved
0.6491 Remote Similarity NPD7524 Approved
0.6471 Remote Similarity NPD5222 Approved
0.6471 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6471 Remote Similarity NPD4697 Phase 3
0.6471 Remote Similarity NPD5221 Approved
0.6462 Remote Similarity NPD6317 Approved
0.6462 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6417 Remote Similarity NPD5173 Approved
0.6412 Remote Similarity NPD6313 Approved
0.6412 Remote Similarity NPD6314 Approved
0.6391 Remote Similarity NPD6909 Approved
0.6391 Remote Similarity NPD6908 Approved
0.6391 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6385 Remote Similarity NPD6868 Approved
0.6372 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6372 Remote Similarity NPD4786 Approved
0.635 Remote Similarity NPD6033 Approved
0.6349 Remote Similarity NPD4729 Approved
0.6349 Remote Similarity NPD4730 Approved
0.6349 Remote Similarity NPD5128 Approved
0.6348 Remote Similarity NPD3573 Approved
0.632 Remote Similarity NPD4767 Approved
0.632 Remote Similarity NPD4768 Approved
0.6316 Remote Similarity NPD5363 Approved
0.6303 Remote Similarity NPD6001 Approved
0.6293 Remote Similarity NPD6672 Approved
0.6293 Remote Similarity NPD5737 Approved
0.629 Remote Similarity NPD4754 Approved
0.6286 Remote Similarity NPD6845 Suspended
0.6283 Remote Similarity NPD5362 Discontinued
0.6283 Remote Similarity NPD7154 Phase 3
0.6283 Remote Similarity NPD6695 Phase 3
0.6273 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6271 Remote Similarity NPD5693 Phase 1
0.6271 Remote Similarity NPD5281 Approved
0.6271 Remote Similarity NPD5284 Approved
0.6271 Remote Similarity NPD6411 Approved
0.6261 Remote Similarity NPD7146 Approved
0.6261 Remote Similarity NPD7334 Approved
0.6261 Remote Similarity NPD6684 Approved
0.6261 Remote Similarity NPD5330 Approved
0.6261 Remote Similarity NPD7521 Approved
0.6261 Remote Similarity NPD6409 Approved
0.626 Remote Similarity NPD1700 Approved
0.625 Remote Similarity NPD5251 Approved
0.625 Remote Similarity NPD5250 Approved
0.625 Remote Similarity NPD4629 Approved
0.625 Remote Similarity NPD5210 Approved
0.625 Remote Similarity NPD5247 Approved
0.625 Remote Similarity NPD5248 Approved
0.625 Remote Similarity NPD5249 Phase 3
0.6239 Remote Similarity NPD4753 Phase 2
0.6207 Remote Similarity NPD7750 Discontinued
0.6202 Remote Similarity NPD5217 Approved
0.6202 Remote Similarity NPD5216 Approved
0.6202 Remote Similarity NPD5215 Approved
0.6195 Remote Similarity NPD3667 Approved
0.6195 Remote Similarity NPD5209 Approved
0.6186 Remote Similarity NPD3168 Discontinued
0.6176 Remote Similarity NPD6067 Discontinued
0.6174 Remote Similarity NPD7520 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data